1+ hour, 35+ min ago  (227+ words) by John Pinching | 7th May 2026 | News Calla Lily Clinical Care has dosed the first patients in its Freedom clinical trial, a nihr'funded study evaluating the company's Callavid intravaginal drug'delivery platform for women with luteal phase insufficiency. The condition, in which progesterone…...